Nextkidney develops the Neokidney™ portable home hemodialysis device and a sorbent technology designed to reduce fluid usage and power consumption. Led by CEO Jérôme Augustin and based in Bussum, Netherlands, the company aims to enhance the dialysis experience and patients' quality of life. The company plans to use recent funding to support clinical trials and secure market clearance for its portable device. The Neokidney system targets at-home treatment by lowering resource requirements through sorbent-based regeneration. Nextkidney raised €11.9M in Series B financing combined with crowdfunding, which it will deploy toward regulatory milestones and clinical studies.

Total raised

$13M

Funding rounds

1

Latest round

Series B

Latest activity

Feb 2023